Secondary Logo

Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access
HELPDESK ANSWERS: PDF Only

Does rifaximin decrease small intestinal bacterial overgrowth in patients with irritable bowel syndrome?

Wright, Kent MD; Middleton, Paul MD; Hudson, Jonell PharmD, BCPS; Coulter, Lois PharmD, BCPS; Vaughn, Brittany MD

Author Information
Evidence-Based Practice: July 12, 2021 - Volume - Issue -
doi: 10.1097/EBP.0000000000001333
  • Buy
  • PAP
© Copyright 2021 Family Physicians Inquiries Network, Inc.